Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers.

scientific article published on 30 March 2016

Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1078-0432.CCR-15-2461
P698PubMed publication ID27029493

P50authorElectron KebebewQ88461842
Martha QuezadoQ110348734
P2093author name stringLisa Zhang
Naris Nilubol
Myriem Boufraqech
Samira M Sadowski
Shweta Kotian
P2860cites workA collection of breast cancer cell lines for the study of functionally distinct cancer subtypesQ24647928
RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasisQ28236828
P433issue17
P407language of work or nameEnglishQ1860
P304page(s)4491-4504
P577publication date2016-03-30
P1433published inClinical Cancer ResearchQ332253
P1476titleLysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers.
P478volume22

Reverse relations

cites work (P2860)
Q61446709A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer
Q47131124Antcin-H Isolated from Antrodia cinnamomea Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-β/c-Fos-MMP-7 Pathways.
Q61805366Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis
Q64067909Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma
Q93005191Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis
Q58772664In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example
Q37406845Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancer
Q58608992Lysyl Oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness
Q49177437Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells
Q92666152Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma
Q94673583Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
Q49388248Molecular Fingerprint for Terminal Abdominal Aortic Aneurysm Disease.
Q96128297Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10
Q92889973Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy
Q91643917Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma
Q94948652Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
Q36369565Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer

Search more.